SPONSOR

University of Aarhus

Total Trials

Recruiting

Phases

Phase 4

Conditions studied: Chronic Rhinosinusitis (Diagnosis)COVID-19 Anosmia Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes Mellitus Cardiovascular Diseases Bodily Distress Disorder Moderate Bodily Distress Disorder Severe Fibromyalgia Chronic Fatigue Syndrome

University of Aarhus is a clinical research sponsor with 23 registered studies on ClinicalTrials.gov, of which 23 are actively recruiting participants. Research covers conditions including Chronic Rhinosinusitis (Diagnosis), COVID-19, Anosmia, Type 2 Diabetes Mellitus (T2DM).

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Aarhus

How many clinical trials has University of Aarhus sponsored?

ClinicalMetric currently tracks 23 clinical trials sponsored by University of Aarhus, of which 23 are actively recruiting participants. These trials cover conditions including Chronic Rhinosinusitis (Diagnosis), COVID-19, Anosmia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Aarhus research focus on?

University of Aarhus clinical trials span Chronic Rhinosinusitis (Diagnosis), COVID-19, Anosmia, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Aarhus clinical trial?

To participate in a University of Aarhus trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Aarhus trials with current recruitment status updated daily.

University of Aarhus

Frequently Asked Questions — University of Aarhus

Clinical Trials by University of Aarhus

The Nasal Microbiome and Its Importance in Disease

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders

Disease Activity Monitoring in Patients With Giant Cell Arteritis Study

Fluorescence-Guided Optimization of Sarcoma Margins

Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy

New Methods for Evaluating Preventive Migraine Treatment

Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy

Effects of Ketone Bodies on Insulin Sensitivity

Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome

The Ventilation During In-hospital Cardiac Arrest Study

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension

A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma

Insulin Resistance in Gestational Diabetes Mellitus

A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma

MY-ENDO -- Mind Your ENDOmetriosis: a Digital Mindfulness- and Acceptance-based Endometriosis Self-management Program

Get Going After concussIonN Lite

Improved Diagnosis of Ovarian Cancer

Application of a Dental-dedicated MRI in the Diagnosis of Temporomandibular Joint Disorders, Tissue Alterations Related to Third Molars, Periapical and Periodontal Inflammatory Diseases, and Implant Treatment Planning

HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants

The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

Combining Treatment Components in Transdiagnostic Therapy for Anxiety and Depression